CN Patent

CN107847432A — D2o稳定化的药物制剂

Assigned to Sydnexis Inc · Expires 2018-03-27 · 8y expired

What this patent protects

本文提供了一种在氘化水中配制的眼用组合物。本文还公开了通过向有需要的个体的眼睛施用有效量的本文所述眼用组合物来治疗、改善或减轻眼科病况或疾病的方法。

USPTO Abstract

本文提供了一种在氘化水中配制的眼用组合物。本文还公开了通过向有需要的个体的眼睛施用有效量的本文所述眼用组合物来治疗、改善或减轻眼科病况或疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN107847432A
Jurisdiction: CN
Classification: —
Expires: 2018-03-27
Drug substance claim: No
Drug product claim: No
Assignee: Sydnexis Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.